- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €329.8m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.30
7D
3.5%
1Y
-21.2%
MPH Health Care
Market Cap: €104.9m
An investment company, engages in the healthcare business in Germany.
93M1
€23.60
7D
-2.1%
1Y
33.3%
Cantourage Group
Market Cap: €73.1m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.82
7D
1.7%
1Y
42.3%
Novogenia
Market Cap: €69.6m
Manufactures and sells personalized health products in global markets.
7V0
€5.80
7D
-3.3%
1Y
n/a